Patient living with hereditary ATTR Amyloidosis by HealthProfessionalRadio 454422 published on 2018-10-09T03:50:31Z Rick, a man in his 60's, talks about living with the rare disease, hereditary ATTR amyloidosis, a rapidly progressive and life-threatening disease, and finding new hope in Alnylam's new treatment, ONPATTRO™ which has just been approved by the FDA in August 2018. Visit www.hpr.fm for more health-related stories and interviews. Genre Science
